Financial News
AstraZeneca: Analysts point to promising pipeline despite Covid vaccine jitters
April 09, 2021 at 08:51 AM EDT
Controversy over AstraZeneca's Covid-19 vaccine has sparked some investor concerns about its stock, according to Jefferies – but it's not all bad news for the British pharmaceutical company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
